Lanréotide Peptides CAS 108736-35-2

99% Lanreotide Peptides Muscle Fitness with Best Quality

Informations de base
Capacité de production:1500kg/mois
Modalités de paiement:T / T, Western union, Money Gram, Bitcoin
Modèle NON.: 108736-35-2
sur mesure: Non-Customized
Convient à: Âgé, Adulte
Pureté: >99%
Marché: Mondial
Marque déposée: WUMEITECH
spécification: 100ml 200ml 500ml
HS Code: 3002200000
Poudre: Oui
Attestation: ISO 9001
État: Solide
Sample: Libre
Usage: Augmenter les gains de masse maigre & Perte de poids
Forfait transport: 1kg/Plastic Bottle or as Required
les athlètes: Made-in-China
99% Lanreotide Peptides Muscle Fitness with Best Quality

Description du produit
Important Notification: All of our products and services listed in this website are for research or production use only, not for direct human use.
Raw powder Lanreotide 108736-35-2

synonymes: LANREOTIDE;AUTOGEL;BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE;BIM-23014;ANGIOPEPTIN;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2;H-D-2-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2, (DISULFIDE BOND);IPSTYL
MF: C54H69N11O10S2
MW: 1096.32
CAS:108736-35-2
Essai:98%
Apparence:white to off-white lyophilised powder

Emballage:plastic vial (dedicated for peptide packing) or glass vial, quantity according to customer’s detail requirement.
Espace de rangement:a cool(2~8 degree C) & dry place protected from light, keep package close when not in use.

Lanreotide——-Pharmacology

Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. toutefois, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.The efficacy of lanreotide has not been extensively studied, and results differ greatly between trials and formulations.

Lanreotide (AUBERGE) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.

Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.

Lanreotide——-Indications

Lanreotide is used in the treatment of acromegaly, due to both pituitary and non-pituitary growth hormone-secreting tumors, and the management of symptoms caused by neuroendocrine tumors, particularly carcinoid tumors and VIPomas. In the United States and Canada, lanreotide is only indicated for the treatment of acromegaly. In the United Kingdom, it is also indicated in the treatment of thyrotrophic adenoma, a rare tumor of the pituitary gland which secretes.

Lanreotide also shows activity against non-endocrine tumors, et, along with other somatostatin analogues, is being studied as a possible general antitumor agent.

Lanreotide ,In Dec 2014 the US FDA approved lanreotide for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Lanreotide——-Effets secondaires

Lanreotide ,The main side effects of lanreotide treatment are mild to moderate pain at the injection site and gastrointestinal disturbances, such as diarrhea, nausea and vomiting. Isolated cases of gallstone formation have been associated with use of lanreotide, particularly over long periods of time.

Administration par voie orale ?

1.) Administration par voie orale.

Administration par voie orale. Administration par voie orale.

1ml(Administration par voie orale) Administration par voie orale 10 Administration par voie orale

1ml(Administration par voie orale) Administration par voie orale 10 Administration par voie orale 10 Administration par voie orale 1 UI

2ml(Administration par voie orale) Administration par voie orale 10 Administration par voie orale

2ml(Administration par voie orale) Administration par voie orale 10 Administration par voie orale 20 Administration par voie orale 1 UI

2.) Administration par voie orale.

3.) Administration par voie orale, tourbillon doux (tourbillon doux) tourbillon doux. tourbillon doux. tourbillon doux.